Spyglass Capital Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.2M | Sell |
|
|||||
|
2025
Q1 | $68.3M | Buy |
|
|||||
|
2024
Q4 | $86.5M | Buy |
|
|||||
|
2024
Q3 | $95.2M | Sell |
|
|||||
|
2024
Q2 | $59.9M | Buy |
|
|||||
|
2024
Q1 | $73.2M | Buy |
|
|||||
|
2023
Q4 | $56.1M | Buy |
|
|||||
|
2023
Q3 | $37.5M | Sell |
|
|||||
|
2023
Q2 | $62.2M | Sell |
|
|||||
|
2023
Q1 | $70.6M | Sell |
|
|||||
|
2022
Q4 | $62.8M | Sell |
|
|||||
|
2022
Q3 | $60.9M | Sell |
|
|||||
|
2022
Q2 | $86.2M | Sell |
|
|||||
|
2022
Q1 | $166M | Sell |
|
|||||
|
2021
Q4 | $208M | Buy |
|
|||||
|
2021
Q3 | $215M | Buy |
|
|||||
|
2021
Q2 | $205M | Buy |
|
|||||
|
2021
Q1 | $203M | Buy |
|
|||||
|
2020
Q4 | $177M | Buy |
|
|||||
|
2020
Q3 | $115M | Buy |
|
|||||
|
2020
Q2 | $80.9M | Buy |
|
|||||
|
2020
Q1 | $41.9M | Buy |
|
|||||
|
2019
Q4 | $35.8M | Buy |
|
|||||
|
2019
Q3 | $11.5M | Buy |
|
|||||
|
2019
Q2 | $8.52M | Buy |
|
|||||
|
2019
Q1 | $5.09M | Sell |
|
|||||
|
2018
Q4 | $5.65M | Buy |
|